23andme company stock.

Freshly listed on the NASDAQ following a business combination with VG Acquisition Corp, a special purpose acquisition company (SPAC), the consumer genetic-testing maven 23andMe (ME-2.24%) is at ...By the time the first Disruptor 50 list was published in 2013, and 23andMe earned a spot on the list, the company had raised more than $50 million from investors. As of last September, the company ...Visit ME's SEC page to see the company's official filings. To visit the company's web site, go to www.23andme.com. ME Valuation Summary. ME's price/earnings ratio is -1.3; this is 105.35% lower than that of the median Healthcare stock. Over the past 38 months, ME's price/sales ratio has gone down 0.1. Below are key valuation metrics over time ...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.

Company Overview. 23andMe is a genomics and biotechnology company that provides health reports to consumers by analyzing their DNA. ... the company's stock price has performed poorly in the recent ...Stock Price Forecast. The 3 analysts offering 12-month price forecasts for 23andMe Holding Co. have a median target of 3.00, with a high estimate of 6.00 ...

Nov 30, 2023 · A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ... Feb 4, 2021 · 23andMe is merging with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson, to go public. The deal values the consumer genetic testing company at $3 ...

See the latest 23andMe Holding Co Class A stock price (ME:XNAS), related news, valuation, dividends and more to help you make your investing decisions.23andMe Stock Price, News & Analysis (NASDAQ:ME) $0.91 -0.02 (-2.15%) (As of 11/27/2023 ET) Compare Today's Range $0.89 $0.93 50-Day Range $0.71 $1.08 …In 2019, 23andMe had a total revenue of $440.9 million. In 2020 during the height of the COVID-19 pandemic, the company’s revenue was $305.5 million. Currently, 23andMe’s trailing twelve-month ...Apr 14, 2023 · ORLANDO, FL - April 14, 2023 -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today announced results from the Phase 1 portion of its Phase 1/2a study evaluating 23ME-00610, an investigational antibody targeting CD200R1. 23ME-00610 demonstrated an acceptable safety and tolerability profile, with favorable pharmacokinetics (PK) and ... Founded in 2006 and headquartered in Sunnyvale, California, 23andMe is a leading consumer genetics and research company. 23andMe’s mission is to help people access, understand, and benefit from ...

Jun 17, 2021 · Shares of 23andMe ( ME) rose 21% to close at $13.32 apiece in their trading debut on the Nasdaq as the consumer genetic testing company became one of the latest companies to go public via SPAC ...

April 19, 2023 at 8:57 AM · 3 min read. When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S") below 1.2x, 23andMe ...

Get a complete List of all S&P 500 stocks. The values of #name# companies consists live prices and previous close price, as well as daily, 3-, 6- and 1-year performance, charts and many more information. Indices Commodities Currencies Stock...Nov 22, 2021 · SUNNYVALE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced that it will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of Class A common stock of 23andMe that were issued under the Warrant ... SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, reported its financial results for the first quarter (Q1) of fiscal year 2024 (FY2024), which ended June 30, 2023. 23andMe is the only company with multiple U.S. Food and Drug ...SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading genetic health and biopharmaceutical company, today launched 23andMe+Total ...23andMe Stock Earnings. The value each ME share was expected to gain vs. the value that each ME share actually gained. 23andMe ( ME) reported Q3 2023 earnings per share (EPS) of -$0.16, missing estimates of -$0.14 by 12.80%. In the same quarter last year, 23andMe 's earnings per share (EPS) was -$0.15. 23andMe is expected to release next ...

Popular spit-in-a-tube genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers.But on Wednesday, one of those partnerships became much more ...This will have shares of VGAC stock switching to the ME stock ticker once the deal closes. The SPAC merger also values 23andMe at $3.5 billion. It will provide the company with $759 million of ...The 23andMe Ancestry DNA testing service offers ancestry breakdowns across 2750+ geographic regions plus insight into your heritage, relatives and more. ... That said, it is possible for a genetic testing company to be wrong about half-siblings. The amount of genetic material shared by half-siblings is 25%, on average. However, the same amount ...27.2%. -28.6%. Market Cap. The market value of a company, in total dollars, also called "market capitalization." Market cap is calculated by taking a company's price per share and multiplying it ...Finding a good stock is tricky, but simple, once you understand how. Use these tips to evaluate companies before purchasing their stock. While investors cannot know everything about any given investment — predicting the future isn't easy — ...

Sept. 20, 2021. Produced by ‘Sway’. Anne Wojcicki is sitting on a treasure trove of genetic data. Wojcicki, a co-founder and the chief executive of the genetic testing company 23andMe, has led ...DNA testing company 23andMe has released further details surrounding an October data breach, where user profile information had been accessed and downloaded at the hands of a threat actor.. On Oct ...

Industry. Biotechnology. No executives to display. Corporate headquarters. --, --. Find real-time ME - 23andMe Holding Co. stock quotes, company profile, news and forecasts from CNN Business.USD$129 USD$79. See how your DNA breaks out across 2750+ regions worldwide with the most comprehensive ancestry breakdown on the market. Discover relatives from near and far with our DNA Relative Finder. Share reports with family and friends. Learn how your DNA influences your facial features, taste, smell and other traits.Investor Relations NASDAQ GS: ME $0.93 +0.0507 (+5.77%) Data Provided by Refinitiv. Minimum 15 minutes delayed. Corporate Profile 23andMe is a leading consumer genetics and research company. Founded in 2006, our mission is to help people access, understand, and benefit from the human genome.We would like to show you a description here but the site won’t allow us.Industry. Biotechnology. No executives to display. Corporate headquarters. --, --. Find real-time ME - 23andMe Holding Co. stock quotes, company profile, news and forecasts from CNN Business.According to a recent report, the genetic testing company 23andMe suffered a data breach that resulted in the data of 6.9 million individuals being leaked. The report from TechCrunch cites an ...Special Bundle Offer: Enter your email to unlock two Health + Ancestry Services for $199. Get two Health + Ancestry Services for $199; third Health + Ancestry Service is $109; each additional Health + Ancestry Service is $229. Offer ends Dec 4. Entry of your email address is not necessary to redeem the offer. Finding a good stock is tricky, but simple, once you understand how. Use these tips to evaluate companies before purchasing their stock. While investors cannot know everything about any given investment — predicting the future isn't easy — ...Oct 7, 2023 · 23andMe’s stock closed down more than 1% percent at $0.86 Friday, continuing a downward trend that first started in October 2021, when the company’s stock was trading at more than $11 per ... SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company with a mission to help people access, understand, and benefit from the human genome, today reported its financial results for the first quarter (“Q1”) of its fiscal …

A high-level overview of 23andMe Holding Co. (ME) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

501 to 1000 Employees. 2 Locations. Type: Company - Public. Founded in 2006. Revenue: Unknown / Non-Applicable. Biotech & Pharmaceuticals. 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the …

23andMe Holding Co. Class A Common Stock (ME) ... Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of …The Registration Statement relates to the offer and sale of an aggregate of 18,286,459 shares (the “Shares”) of Class A common stock, par value $0.0001 per share, of the Company, which consists of (i) 13,714,844 shares reserved for issuance under the 23andMe Holding Co. 2021 Incentive Equity Plan (the “Equity Plan”) and (ii) 4,571,615 ...Sundry Photography. US Sen. Bill Cassidy (R-La.), the ranking member of the Senate health committee, has reportedly asked the CEO of 23andMe ( NASDAQ: ME) to provide his committee with details ...23andme Holding Co stock was originally listed at a price of $9.91 in Oct 2, 2020. If you had invested in 23andme Holding Co stock at $9.91, your return over the …By the time the first Disruptor 50 list was published in 2013, and 23andMe earned a spot on the list, the company had raised more than $50 million from investors. As of last September, the company ...The deal will help drive additional investment in key growth initiatives across 23andMe’s consumer health and therapeutics businesses, the company said. The stock and cash transaction is ...23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.SUNNYVALE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced that it will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of Class A common stock of 23andMe that were issued under the Warrant ...Dec 1, 2023 · See the latest 23andMe Holding Co Class A stock price (ME:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Why 23andMe Holding Stock Plummeted by 13% Today Investors reacted sharply and not well to the company's inaugural set of fiscal 2024 earnings. Eric Volkman | Aug 9, 2023

Richard Branson’s company is joining forces with 23andMe through what is known as a ‘blank-check company’. ... after which the company will begin trading on the New York stock exchange under ...26 Jun 2023 ... Shares of 23andMe Holdings (ME), a consumer genetics and research company, crumbled 68% in 2022, a year that saw its chief financial officer ...In 2019, 23andMe had a total revenue of $440.9 million. In 2020 during the height of the COVID-19 pandemic, the company’s revenue was $305.5 million. Currently, 23andMe’s trailing twelve-month ...23andMe (ME) stock gained ~11% on Monday after announcing that hackers accessed only 0.1% of customer accounts during a recent data breach. Read more here.Instagram:https://instagram. barrick gold stock price todaybig lots newsbbh etfwhere can i buy world coin Dan Chu joined 23andMe as Chief Product Officer in September 2022, as the company embarks on transforming healthcare to deliver a more personalized experience. Prior to 23andMe, Dan was the Chief Product Officer for Waymo where he launched the world's first commercial fully autonomous ride-hailing service. stock ccicsco dividend date 4 Feb 2021 ... The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion.Why 23andMe Holding Stock Plummeted by 13% Today. ME | Complete 23andMe Holding Co. stock news by MarketWatch. View real-time stock prices and stock quotes for a full … marketwatch hasi The Company continued to add reports for 23andMe+ members, and launched a collaboration with Novartis for disease awareness. ... Common stock, par value $0.0001 - Class A shares, 1,140,000,000 ...ME Earnings Date and Information. 23andMe last issued its quarterly earnings data on November 8th, 2023. The reported ($0.16) EPS for the quarter. The firm earned $50 million during the quarter, compared to the consensus estimate of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) …